After a storm of criticism, Lina Khan’s FTC has a $7 billion victory related to a cancer-test acquisition
Gene sequencing company Illumina will divest subsidiary Grail after a court found it broke antitrust laws in the 2021 acquisition.
Gene sequencing company Illumina will divest subsidiary Grail after a court found it broke antitrust laws in the 2021 acquisition. Read More
